LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems today announced it had signed a collaborative framework agreement with Chung Shan Medical University Hospital and ASYS Corp to provide advanced proton therapy in Central Taiwan. This agreement followed the formation of a partnership between Mevion and ASYS Corp, a leading provider of system integration engineering, sales, and services for the biomedical healthcare industry since 2003.
Founded in 1966, Chung Shan Medical University Hospital is well established as the leading healthcare provider in the central region of Taiwan. It has been proactively exploring advanced therapies, such as proton therapy, for better patient outcomes.
"We believe incorporating proton therapy to our hospital is a critical, strategic decision to advance our role as a world-class teaching, research, and clinical institution,” said Dr. Chien-Ning Huang, President of Chung Shan Medical University Hospital. “We are excited to be partnering with Mevion to provide industry-leading proton therapy to our patients as well as an excellent platform for research and teaching programs.”
This October, Dr. Huang presented at the Mevion Proton Symposium during the China Society for Radiation Oncology Meeting (CSTRO). As he introduced, there are two operating proton centers in Taiwan and six more in planning or construction phases. Fully taking advantage of its high quality of healthcare and competitive cost of treatment, Taiwan has the potential to become a proton therapy hub for local and international cancer patients.
“Proton therapy and clinical sciences are rapidly advancing in Taiwan. Next year, the 59th Annual Conference of the Particle Therapy Co-Operative Group will be held here, highlighting the scientific advances being made in Taiwan,” said Dr. James Meng, President of Mevion Medical Systems. “We are honored to be selected by Chung Shan Medical University Hospital in their mission to better serve their patients, which so closely aligns with our own. We are also fortunate to have such a respected and experienced local partner, ASYS, to make this project possible.”
“As a trusted advanced system integrator for the past two decades, we are proud to be bringing this life-saving technology to our market through this partnership with Mevion and Chung Shan Medical University Hospital,” said Edward Lee, President of ASYS Corp.
Proton therapy is a more precise therapeutic radiation to the tumor and less damaging to nearby organs. It is becoming a favored tool among top centers around the world. Mevion provides the most compact and precise proton systems available today and has been selected by leading clinical centers in the U.S., Europe, and China.
About Mevion Medical Systems
Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with a presence in Europe, and Asia. For more information, please visit www.mevion.com